Dynamic cell-cell and cell-ECM interactions in the heart

Journal of Molecular and Cellular Cardiology

Volumn 70, Issue , 2014, Pages 19-26

  Howard, Catherine M ^a   Baudino, Troy A ^b,c  

^a BAYLOR UNIVERSITY   (United States)

^b TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Cardiac fibroblasts; Cardiac remodeling; Cell cell interactions; Extracellular matrix; Myocytes

Indexed keywords

MICRORNA;

CELL COMMUNICATION; CHEMISTRY; CONVALESCENCE; CYTOLOGY; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; FIBROBLAST; HEART; HEART INJURY; HEART MUSCLE CELL; HUMAN; MECHANOTRANSDUCTION; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

CELL COMMUNICATION; ENDOTHELIAL CELLS; EXTRACELLULAR MATRIX; FIBROBLASTS; HEART; HEART INJURIES; HUMANS; MECHANOTRANSDUCTION, CELLULAR; MICRORNAS; MYOCYTES, CARDIAC; RECOVERY OF FUNCTION;

EID: 84898811349     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2013.10.006     Document Type: Review

References (86)

1. Chien K.R., Domian I.J., Parker K.K. Cardiogenesis and the complex biology of regenerative cardiovascular medicine. Science 2008, 322:1494-1497.
2. Shiraishi I., Takamatsu T., Minamikawa T., Onouchi Z., Fujita S. Quantitative histological analysis of the human sinoatrial node during growth and aging. Circ Res 1992, 85:2176-2184.
3. Camelliti P., Borg T., Kohl P. Structural and functional characterization of cardiac fibroblasts. Cardiovasc Res 2005, 65:40-51.
4. Baudino T., Carver W., Giles W., Borg T.K. Cardiac fibroblasts: friend or foe?. Am J Physiol Heart Circ Physiol 2006, 291:H1015-H1026.
5. Kakur R., Lee R. Intramyocardial fibroblast myocyte communication. Circ Res 2010, 106:47-57.
6. Banerjee I., Yekkala K., Borg T.K., Baudino T.A. Dynamic interactions between myocytes, fibroblasts, and extracellular matrix. Ann N Y Acad Sci 2006, 1080:76-84.
7. Campbell S.E., Katwa L.C. Angiotensin II stimulated expression of transforming growth factor-b, in cardiac fibroblasts and myofibroblasts. J Mol Cell Cardiol 1997, 29:1947-1958.
8. Chen M.M., Lam A., Abraham J.A., Schreiner G.F., Joly A.H. CTGF expression is induced by TGF-beta in cardiac fibroblasts and cardiac myocytes: a potential role in heart fibrosis. J Mol Cell Cardiol 2000, 32:1805-1819.
9. Chilton L., Giles W.R., Smith G.L. Evidence of intercellular coupling between co-cultured adult rabbit ventricular myocytes and myofibroblasts. J Physiol 2007, 583:225-236.
10. Camelliti P., Green C.R., LeGrice I., Kohl P. Fibroblast network in rabbit sinoatrial node - structural and functional identification of homogeneous and heterogeneous cell coupling. Circ Res 2004, 94:828-835.
11. Gaudesius G., Miragoli M., Thomas S.P., Rohr S. Coupling of cardiac electrical activity over extended distances by fibroblasts of cardiac origin. Circ Res 2003, 93:421-428.
12. Goncharova E.J., Kam Z., Geiger B. The involvement of adherens junction components in myofibrillogenesis in cultured cardiac myocytes. Development 1992, 114:173-183.
13. Baudino T.A., McFadden A., Fix C., Hastings J., Price R., Borg T.K. Cell patterning: interaction of cardiac myocytes and fibroblasts in three-dimensional culture. Microsc Microanal 2008, 14:117-125.
14. Katz T.C., Singh M.K., Degenhardt K., Ribera-Feliciano J., Johnson R.L., Epstein J.A., et al. Distinct compartments of the proepicardial organ give rise to coronary vascular endothelial cells. Dev Cell 2012, 22:639-650.
15. Kanekar S., Hirozanne T., Terracio L., Borg T.K. Cardiac fibroblasts: form and function. Cardiovasc Pathol 1998, 7:127-133.
16. Souders C.A., Bowers S.L., Baudino T.A. Cardiac fibroblast: the renaissance cell. Circ Res 2009, 105:1164-1176.
17. Strutz F., Okada H., Lo C.W., Danoff T., Carone R.L., Tomaszewski J.E., et al. Identification and characterization of a fibroblast marker: FSP1. J Cell Biol 1995, 130:393-405.
18. Mazzucchelli L. Protein S100A4: too long overlooked by pathologists?. Am J Pathol 2002, 160:7-13.
19. Goldsmith E.C., Hoffman A., Morales M.O., Potts J.D., Price R.L., McFadden A., et al. Organization of fibroblasts in the heart. Dev Dyn 2004, 230:787-794.
20. Valencia X., Higgins J.M.G., Kiener H.P., Lee D.M., Podrebarac T.A., Dascher C.C., et al. Cadherin-11 provides specific cellular adhesion between fibroblast-like synoviocytes. J Exp Med 2004, 200:1673-1679.
21. Simoneau L., Kitagawa M., Suzuki S., Thiery J.P. Cadherin-11 expression marks the mesenchymal phenotype: towards new functions for cadherins?. Cell Adhes Commun 1995, 3:115-130.
22. Lane E.B., Hogan B.L., Kurkinen M., Garrels J.I. Co-expression of vimentin and cytokeratins in parietal endoderm cells of early mouse embryo. Nature 1983, 303:701-704.
23. Duprey P., Paulin D. What can be learned from intermediate filament gene regulation in the mouse embryo?. Int J Dev Biol 1995, 39:443-457.
24. Norris R.A., Potts J.D., Yost M.J., Junor L., Brooks T., Tan H., et al. Periostin promotes a fibroblastic lineage pathway in atrioventricular valve progenitor cells. Dev Dyn 2009, 238:1052-1063.
25. Oka T., Xu J., Kaiser R.A., Melendez J., Hambleton M., Sargent M.A., et al. Genetic manipulation of periostin expression reveals a role in cardiac hypertrophy and ventricular remodeling. Circ Res 2007, 101:313-321.
26. Kruzynska-Frejtag A., Machnicki M., Rogers R., Markwald R.R., Conway S.J. Periostin (an osteoblast-specific factor) is expressed within the embryonic mouse heart during valve formation. Mech Dev 2001, 103:183-188.
27. Tomasek J.J., Gabbiani G., Hinz B., Chaponnier C., Brown R.A. Myofibroblasts and mechano-regulation of connective tissue remodeling. Nat Rev Mol Cell Biol 2002, 3:349-363.
28. Brown E., Dejana E. Cell-to-cell contact and extracellular matrix. Editorial overview: cell-cell and cell-matrix interactions - running, jumping, and standing still. Curr Opin Cell Biol 2003, 15:505-508.
29. Calderone A., Bel-Hadj S., Drapeau J., El-Helou V., Gosselin H., Clement R., et al. Scar myofibroblasts of the infarcted rat heart express natriuretic peptides. J Cell Physiol 2006, 207:165-173.
30. Kamkin A., Kiseleva I., Lozinsky I., Scholz H. Electrical interaction of mechanosensitive fibroblasts and myocytes in the heart. Basic Res Cardiol 2005, 100:337-345.
31. Kamkin A., Kiseleva I., Isenberg G., Wagner K.D., Günther J., Theres H., et al. Cardiac fibroblasts and the mechano-electric feedback mechanism in healthy and diseased hearts. Prog Biophys Mol Biol 2003, 82:111-120.
32. Bennett P.M., Maggs A.M., Baines A.J., Pinder J.C. The transitional junction: a new functional subcellular domain at the intercalated disc. Mol Biol Cell 2006, 17:2091-2100.
33. Gutstein D.E., Liu F.Y., Meyers M.B., Choo A., Fishman G.I. The organization of adherens junctions and desmosomes at the cardiac intercalated disc is independent of gap junctions. J Cell Sci 2003, 116:875-885.
34. Estigoy C.B., Pontén F., Odeberg J., Herbert B., Guilhaus M., Charleston M., et al. Intercalated discs: multiple proteins perform multiple functions in non-failing and failing human hearts. Biophys Rev 2009, 1:43-49.
35. Fearnley C., Roderick H.L., Bootman M.D. Calcium signaling in cardiac myocytes. Cold Spring Harb Perspect Biol 2011, 3:1-21.
36. Gutstein D.E., Liu F.Y., Meyers M.B., Choo A., Fishman G.I. The organization of adherens junctions and desmosomes at the cardiac intercalated disc is independent of gap junctions. J Cell Sci 2003, 116:875-885.
37. Ballard-Croft C., White D.J., Maass D.L., Hybki D.P., Horton J.W. Role of p38 mitogen-activated protein kinase in cardiac myocyte secretion of the inflammatory cytokine TNF-〈. Am J Physiol Heart Circ Physiol 2001, 280:H1970-H1981.
38. Bryant D., Becker L., Richardson J., Shelton J., Franco F., Peshock R., et al. Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-〈. Circulation 1998, 97:1375-1381.
39. Bowers S.L., Baudino T.A. Cardiac myocyte-fibroblast interactions and the coronary vasculature. J Cardiovasc Trans Res 2012, 5:783-793.
40. Pinsky D.J., Patton S., Mesaros S., Brovkovych V., Kubaszewski E., Grunfeld S., et al. Mechanical transduction of nitric oxide synthesis in the beating heart. Circ Res 1997, 81:371-379.
41. Schulz R., Nava E., Moncada S. Induction and potential biological relevance of a Ca(2+)-independent nitric oxide synthase in the myocardium. J Pharmacol 1992, 105:575-580.
42. Harrison D.G., Widder J., Grumbach I., Chen W., Weber M., Searles C. Endothelial mechanotransduction, nitric oxide and vascular inflammation. J Intern Med 2006, 259:351-363.
43. Noden D.M. Origin and patterning of avian outflow tract endocardium. Development 1991, 111:867-876.
44. Darland D.C., D'Amore P.A. Cell-cell interactions in vascular development. Curr Top Dev Biol 2001, 52:107-149.
45. Davis G.E., Senger D.R. Endothelial extracellular matrix: biosynthesis, remodeling, and functions during vascular morphogenesis and neovessel stabilization. Circ Res 2005, 97:1093-1107.
46. Armulik A., Abramsson A., Betsholtz C. Endothelial/pericyte interactions. Circ Res 2005, 97:512-523.
47. Stratman A.N., Malotta K.M., Mahan R.D., Davis M.J., Davis G.E. Pericyte recruitment during vasculogenic tube assembly stimulates endothelial basement membrane matrix formation. Blood 2009, 114:5091-5101.
48. Streeter D.D. Gross morphology and fiber geometry of the heart. Handb Physiol 1979, 1:61-112.
49. Borg T.K., Caulfield J.B. The collagen matrix of the heart. Fed Proc 1981, 40:2037-2041.
50. Kong D., Li Y., Wang Z., Banerjee S., Sarkar F.H. Inhibition of angiogenesis and invasion by 3,3'-diindolylmethane is mediated by the NF-β downstream target genes MMP-9 and uPA that regulated bioavailability of VEGF in prostate cancer. Cancer Res 2007, 67:3310-3319.
51. Goldsmith E.C., Borg T.K. The dynamic interaction of the extracellular matrix in cardiac remodeling. J Card Fail 2002, 8:S314-S318.
52. Terracio L., Rubin K., Gullberg D., Balog E., Carver W., Jyring R., et al. Expression of collagen binding integrins during cardiac development and hypertrophy. Circ Res 1991, 68:734-744.
53. Borg T.K., Klevay L.M., Gay R.E., Siegel R., Bergin M.E. Alteration of the connective tissue network of striated muscle in copper deficient rats. Cardiology 1985, 17:1173-1183.
54. Lockhard M., Wirrig E., Wessels A. Extracellular matrix and heart development. Birth Defects Res A Clin Mol Teratol 2011, 91:535-550.
55. Raffetto J.D., Khalil R.A. Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease. Biochem Pharmacol 2008, 75:346-359.
56. Lotz M., Guerne P.A. Interleukin-6 induces the synthesis of tissue inhibitor of metalloproteinases-1/erythroid potentiating activity (TIMP-1/EPA). J Biol Chem 1991, 266:2017-2020.
57. Fearon U., Reece R., Smith J., Emery P., Veale D.J. Synovial cytokine and growth factor regulation of MMPs/TIMPs: implications for erosions and angiogenesis in early rheumatoid and psoriatic arthritis patients. Ann N Y Acad Sci 1999, 878:619-621.
58. Midgley A.C., Rogers M., Hallett M.B., Clayton A., Bowen T., Phillips A.O., et al. Transforming growth factor-®1 (TGF-®1)-stimulated fibroblast to myofibroblast differentiation is mediated by hyaluronan (HA)-facilitated epidermal growth factor receptor (EGFR) and CD44 co-localization in lipid rafts. J Biol Chem 2013, 288:14824-14838.
59. Sabbah H.N., Sharov V.G., Lesch M., Soldstein S. Progression of heart failure: a role for interstitial fibrosis. Mol Cell Biochem 1995, 147:29-34.
60. Kohl P., Camelliti P., Burton F.L., Smith G.L. Electrical coupling of fibroblasts and myocytes: relevance for cardiac propagation. J Electrocardiol 2005, 38:45-50.
61. Vasquez C., Mohandas P., Louie K.L., Benamer N., Bapat A.C., Morley G.E. Enhanced fibroblast-myocyte interactions in response to cardiac injury. Circ Res 2010, 107:1011-1020.
62. Chilton L., Ohya S., Freed D., George E., Drobic V., Shibukawa Y., et al. K+ currents regulate the resting membrane potential, proliferation, and contractile responses in ventricular fibroblasts and myofibroblasts. Am J Physiol Heart Circ Physiol 2005, 288:H2931-H2939.
63. Takeda N., Manabe I. Cellular interplay between cardiomyocytes and nonmyocytes in cardiac remodeling. Int J Inflamm 2011, 2011:1-13.
64. Yang Y.C., Piek E., Zavadil J., Liang D., Xie D., Heyer J., et al. Hierarchical model of gene regulation by transforming growth factor beta. Proc Natl Acad Sci U S A 2003, 100:10269-10274.
65. Yamazaki T., Komuro I., Kudoh S., Zou Y., Shiojima I., Hiroi Y., et al. Endothelin-1 is involved in mechanical stress-induced cardiomyocyte hypertrophy. J Biol Chem 1996, 271:3221-3228.
66. Jiang Z.S., Jeyaraman M., Wen G.B., Fandrich R.R., Dixon I.M., Cattini P.A., et al. High- but not low-molecular weight FGF-2 causes cardiac hypertrophy in vivo; possible involvement of cardiotrophin-1. J Mol Cell Cardiol 2007, 42:222-233.
67. Pontén A., Li X., Thorén P., Aase K., Sjöblom T., Ostman A., et al. Transgenic overexpression of platelet-derived growth factor-C in the mouse heart induces cardiac fibrosis, hypertrophy, and dilated cardiomyopathy. Am J Pathol 2003, 163:673-682.
68. Takeda N., Manabe I., Uchino Y., Eguchi K., Matsumoto S., Nishimura S., et al. Cardiac fibroblasts are essential for the adaptive response of the murine heart to pressure overload. J Clin Invest 2010, 120:254-265.
69. Bowers S.L., Borg T.K., Baudino T.A. The dynamics of fibroblast-myocyte-capillary interactions in the heart. Ann N Y Acad Sci 2010, 1188:143-152.
70. Emerson G.G., Segal S.S. Electrical coupling between endothelial cells and smooth muscle cells in hamster feed arteries. Circ Res 2000, 87:474-479.
71. Rychli K., Kaun C., Hohensinner P., Dorfner A., Pfaffenberger S., Niessner A., et al. The antiangiogenic factor PEDF is present in the human heart and is regulated by anoxia in cardiac myocytes and fibroblasts. J Cell Mol Med 2010, 14:198-205.
72. Powell D.W., Mifflin R.C., Valentich J.D., Crowe S.E., Saada J.I., West A.B. Myofibroblasts. I. Paracrine cells important in health and disease. Am J Physiol Cell Physiol 1999, 277:C1-C19.
73. Lambert E., Dasse E., Haye B., Petitfrere E. TIMPs as multifacial proteins. Crit Rev Oncol Hematol 2004, 49:187-198.
74. Yamada E., Tobe T., Yamada H., Okamoto N., Zack D.J., Werb Z., et al. TIMP-1 promotes VEGF induced neovascularization in the retina. Histol Histopathol 2001, 16:87-97.
75. Liu H., Chen B., Lilly B. Fibroblasts potentiate blood vessel formation partially through secreted factor TIMP-1. Angiogenesis 2008, 11:223-234.
76. Ingber D.E. Mechanical signaling and the cellular response to extracellular matrix in angiogenesis and cardiovascular physiology. Circ Res 2002, 91:877-887.
77. Doebele C., Bonauer A., Fischer A., Scholz A., Reiss Y., Urbich C., et al. Members of the microRNA-17-92 cluster exhibit a cell-intrinsic antiangiogenic function in endothelial cells. Blood 2010, 115:4944-4950.
78. Kukreja R.C., Yin C., Salloum F.N. MicroRNAs: new players in cardiac injury and protection. Mol Pharmacol 2011, 80:558-564.
79. Bonauer A., Carmona G., Iwasaki M., Mione M., Koyanagi M., Fischer A., et al. MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science 2009, 324:1710-1713.
80. Fish J.E., Santoro M.M., Morton S.U., Yu S., Yeh R.F., Wythe J.D., et al. miR-126 regulates angiogenic signaling and vascular integrity. Dev Cell 2008, 15:272-284.
81. Sucharov C., Bristow M.R., Port J.D. miRNA expression in the failing human heart: functional correlates. J Mol Cell Cardiol 2008, 45:185-192.
82. van Rooij E., Sutherland L.B., Liu N., Williams A.H., McAnally J., Gerard R.D., et al. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci U S A 2006, 103:18255-18260.
83. Brutsaert D.L. Cardiac endothelial-myocardial signaling: its role in cardiac growth, contractile performance, and rhythmicity. Physiol Rev 2003, 83:59-115.
84. Narmoneva D.A., Vukmirovic R., Lee R.T. Endothelial cells promote cardiac myocyte survival and spatial reorganization. Circ Res 2004, 110:962-968.
85. Giordano F.J., Gerber H.P., Williams S.P., VanBruggen N., Bunting S., Ruiz-Lozano P., et al. A cardiac myocyte vascular endothelial growth factor paracrine pathway is required to maintain cardiac function. Proc Natl Acad Sci U S A 2001, 98:5780-5785.
86. Givvimani S., Qipshidze N., Tyagi S.C. Synergism between arrhythmia and hyperhomo-cysteinemia in structural heart disease. Int J Physiol Pathophysiol Pharmacol 2011, 3:107-119.